“Despite efforts, the stigma around Leprosy still prevails,” observes Dr. Pallavi Kashyap, Consultant Leprologist

▴
“More awareness and more priority has to be given to leprosy eradication programs to fight the stigma attached to it,” says Dr. Pallavi Kashyap, Consultant Leprologist.

Dr. Pallavi Kashyap is a practicing consultant leprologist, dermatologist and venereologist. She has done her thesis on Lepra Reactions and has treated patients with all kinds of Leprosy. She practices from her OPD in Patna.

Research Findings

Dr. Kashyap informs that in her thesis, she specifically worked for patients suffering from Lepra reaction of both type 1 and type 2, and found out that ”patients who are G6PD deficient are more prone for Lepra reactions and should not be given Dapsone as a part of MDT in their therapy.” 

Why re-emergence of Leprosy in India 

Dr. Kashyap lists down some causes of re-emergence of leprosy cases in India after it had got completely eradicated in the year 2005:

“Work of National Leprosy Eradication Programme (NLEP) is completely appreciable when it comes to leprosy eradication in India but the reasons of recurrence are the defaulter cases and lack of awareness amongst the patients to complete the therapy. The Indian MDT therapy where the Rifampicin is given 600mg once a month is also a problem as it is causing drug resistance and a once-monthly dose is not sufficient in most Leprosy Patients. Whereas, the CDC ( Center of disease control) therapy where RIfampicin is given 450mg daily along with Dapsone and Clofazimine in respective doses proves more effective and should be adopted,”says Dr. Kashyap

The stigma needs to be eradicated

Dr. Kashyap emphasizes:

“The basic idea behind leprosy eradication is the stigma attached to it. Unfortunately despite various efforts, the stigma still prevails hence more awareness and more priority has to be given to Leprosy eradication programmes. In Fact, the treating consultants should actually educate the patient attenders.  The spread can also be stopped by screening the family members of the leprosy patients. The treatment should be easily available to the patients and most importantly, patients should be aware of the duration of the treatment as recurrence and lack of completion of the treatment is one of the major causes of spread and prevalence of Leprosy in our country, " says Dr. Kashyap.

BCG vaccine to children provides immunity from M.leprae

Dr. Kashyap points out that “leprosy vaccine is available but it is not included in the immunization schedule for children because BCG vaccination is already given to children which provide similar immunity and protection. Exposure to environmental mycobacteria with cross-reacting antigens to M.leprae could modify the immune response post-vaccination and alter the protective efficacy of the vaccines against leprosy. Most importantly, Leprosy can be completely treated with MDT if detected at the right time and if given for the right duration of time.”


(Edited by Amrita Priya)

 

Contributed By: Dr. Pallavi Kashyap, Consultant Leprologist

 

Tags : #medicircle #smitakumar #drpallavikashyap #leprologist #leprosy #leprosystigma #World-Leprosy-Day-Awareness-Series

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026